Economy · World
AstraZeneca and Insitro Announce AI Drug Discovery Partnership
Pharmaceutical company AstraZeneca has entered into a significant artificial intelligence-driven drug discovery partnership with Insitro. The deal is valued at up to $40 million, according to The Economic Times, and up to $1.5 billion according to The Wall Street Journal. The collaboration will focus on using AI to accelerate the discovery of new medicines.
How outlets across the spectrum covered it
L 0 C 2 R 0
- Centre (2): The Economic Times, The Wall Street Journal